Perbak Capital Partners’s Hinge Health HNGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-7,138
Closed -$275K 288
2026
Q1
$275K Buy
7,138
+458
+7% +$19K 0.07% 265
2025
Q4
$310K Sell
6,680
-8,524
-56% -$411K 0.09% 133
2025
Q3
$746K Buy
+15,204
New +$795K 0.13% 174

Other funds holding HNGE

Perbak Capital Partners's HNGE Position: Q2 2026 in Review

Perbak Capital Partners sold out of Hinge Health (HNGE) in Q2 2026, closing a stake of 7,138 shares — an estimated $275K sold.

Perbak Capital Partners first reported a position in HNGE in Q3 2025 and held it in 3 quarters. The position peaked at $746K in Q3 2025. 277 funds tracked by Wall St. Rank hold HNGE as of Q2 2026.

  • Perbak Capital Partners reported no remaining Hinge Health position as of Q2 2026 after selling out during the quarter.
  • Perbak Capital Partners sold 7,138 Hinge Health shares in Q2 2026, an estimated $275K.
  • Perbak Capital Partners first reported a position in Hinge Health in Q3 2025 and held it in 3 quarters.
  • Perbak Capital Partners's Hinge Health position peaked at $746K in Q3 2025.
  • 277 funds tracked by Wall St. Rank held Hinge Health as of Q2 2026.

Based on Perbak Capital Partners's 13F filing for Q2 2026.